Literature DB >> 2994477

Genital herpes in pregnancy: risk factors associated with recurrences and asymptomatic viral shedding.

Z A Brown, L A Vontver, J Benedetti, C W Critchlow, D E Hickok, C J Sells, S Berry, L Corey.   

Abstract

One hundred forty-seven women with recurrent symptomatic genital herpes simplex virus acquired prior to the start of pregnancy (group 1) and 15 women whose first symptomatic episode of genital herpes was acquired during pregnancy (group 2) were followed weekly during the course of gestation. Among women with recurrent genital herpes antedating pregnancy, the mean number of recurrences per trimester increased from 0.97 to 1.26 to 1.63 in the first through third trimester, respectively (p less than 0.05 for comparison between each trimester). The median number of symptomatic recurrences of genital herpes during gestation was four in women in group 1 compared to one in women in group 2 (p less than 0.01). Asymptomatic viral excretion from the genital tract was, however, more common in women in group 2 (33%) than in women in group 1 (12.9%) (p less than 0.05). Herpes simplex virus was isolated at 5.5% of routine visits in group 2 women compared to 1% of routine visits among group 1 women. Logistic regression analysis indicated young age also was associated with more frequent asymptomatic viral shedding. Asymptomatic herpes simplex virus excretion was more common from the vulvar area than the cervix, and women in group 2 were more likely to shed virus from both sites simultaneously than women in group 1. Age and recent acquisition of genital herpes are risk factors for asymptomatic excretion of herpes simplex virus during pregnancy.

Entities:  

Mesh:

Year:  1985        PMID: 2994477     DOI: 10.1016/0002-9378(85)90584-8

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  15 in total

1.  Toward the rational management of herpes infection in pregnant women and their newborn infants. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1992-05-01       Impact factor: 8.262

Review 2.  Current recommendations for the treatment of genital herpes.

Authors:  D T Leung; S L Sacks
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

3.  Neonatal herpes simplex virus infection.

Authors:  Thomas L Cherpes; Dean B Matthews; Samantha A Maryak
Journal:  Clin Obstet Gynecol       Date:  2012-12       Impact factor: 2.190

4.  17-beta estradiol promotion of herpes simplex virus type 1 reactivation is estrogen receptor dependent.

Authors:  Rodolfo D Vicetti Miguel; Brian S Sheridan; Stephen A K Harvey; Robert S Schreiner; Robert L Hendricks; Thomas L Cherpes
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

Review 5.  Pregnancy and infection.

Authors:  Athena P Kourtis; Jennifer S Read; Denise J Jamieson
Journal:  N Engl J Med       Date:  2014-06-05       Impact factor: 91.245

6.  Changes in immunoglobulin levels related to herpes simplex virus type 1 brain infection in pregnant mice.

Authors:  Javier S Burgos; Carlos Ramirez; Anna Brachet; Juan M Alfaro; Isabel Sastre; Fernando Valdivieso
Journal:  J Neurovirol       Date:  2007-06       Impact factor: 2.643

7.  Pregnancy and sexually transmitted viral infections.

Authors:  P Singhal; S Naswa; Y S Marfatia
Journal:  Indian J Sex Transm Dis AIDS       Date:  2009-07

8.  Reproductive tract infections in HIV positive women: A case control study.

Authors:  Archana Sharma; Y S Marfatia; Megha Modi
Journal:  Indian J Sex Transm Dis AIDS       Date:  2009-01

Review 9.  Pregnancy and susceptibility to infectious diseases.

Authors:  Elisabeth Sappenfield; Denise J Jamieson; Athena P Kourtis
Journal:  Infect Dis Obstet Gynecol       Date:  2013-07-07

10.  Acyclovir suppression to prevent recurrent genital herpes at delivery.

Authors:  L L Scott; L M Hollier; D McIntire; P J Sanchez; G L Jackson; G D Wendel
Journal:  Infect Dis Obstet Gynecol       Date:  2002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.